AnalystsPatrick R. TrucchioPatrick R. Trucchio's Stock Forecasts
AnalystsPatrick R. Trucchio
Sectors:
Industries:
Analyst Ranking
Top 6%
#313 out of 5326 analysts
Average Return
+26.22%
Win Rate
57%58 out of 101
Risk vs Reward
Poor
Good
Patrick R. Trucchio's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alto Neuroscience IncANRO | +707.62% | $3.41 | $27.54 | 2025-08-18 - 2026-07-17 | Buy |
Arrowhead Pharmaceuticals IncARWR | +189.33% | $25.68 | $74.30 | 2025-09-02 - 2026-07-17 | Buy |
Definium Therapeutics IncDFTX | +157.80% | $17.18 | $44.29 | 2026-03-02 - 2026-07-17 | Buy |
Alto Neuroscience IncANRO | +150.36% | $11.00 | $27.54 | 2025-10-24 - 2026-07-17 | Buy |
Nrx Pharmaceuticals IncNRXP | +137.22% | $1.80 | $4.27 | 2026-03-03 - 2026-07-17 | Buy |
Patrick R. Trucchio Analyst Color
Get additional color on Patrick R. Trucchio's coverage of popular stocks
Patrick R. Trucchio's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Harmony Biosciences Holdings IncHRMY | 4 | Buy | $55.00 | +62.87% | Reiterates | 4 days ago |
Alnylam Pharmaceuticals IncALNY | 9 | Buy | $485.00 | +81.33% | Maintains | 7 days ago |
Cybin IncHELP | 3 | Buy | $70.00 | +865.52% | Maintains | 11 days ago |
Precision Biosciences IncDTIL | 2 | Buy | $60.00 | +662.39% | Reiterates | 11 days ago |
Compass Pathways PLCCMPS | 3 | Buy | $70.00 | +466.80% | Reiterates | 12 days ago |
Beam Therapeutics IncBEAM | 3 | Buy | $80.00 | +190.59% | Reiterates | 13 days ago |
Arrowhead Pharmaceuticals IncARWR | 7 | Buy | $100.00 | +34.59% | Reiterates | 19 days ago |
Uniqure NvQURE | 9 | Buy | $80.00 | +98.76% | Maintains | 21 days ago |
Gossamer Bio IncGOSS | 4 | Buy | $2.00 | +1,076.47% | Maintains | 25 days ago |
Faeth Therapeutics IncFTH | 1 | Buy | $60.00 | +131.93% | Initiates Coverage On | a month ago |
Agomab Therapeutics NvAGMB | 1 | Buy | $35.00 | +190.70% | Initiates Coverage On | a month ago |
Silence Therapeutics PLCSLN | 3 | Buy | $75.00 | +614.29% | Reiterates | a month ago |
Invivyd IncIVVD | 4 | Buy | $10.00 | +1,245.90% | Reiterates | a month ago |
Ataibeckley IncATAI | 4 | Buy | $25.00 | +246.26% | Reiterates | a month ago |
Bright Minds Biosciences IncDRUG | 5 | Buy | $145.00 | N/A | Reiterates | 2 months ago |
Oncolytics Biotech IncONCY | 2 | Buy | $10.00 | +1,072.33% | Reiterates | 2 months ago |
Gh Research PLCGHRS | 3 | Buy | $65.00 | +126.40% | Maintains | 2 months ago |
Altimmune IncALT | 4 | Buy | $20.00 | +596.86% | Maintains | 2 months ago |
Alto Neuroscience IncANRO | 4 | Buy | $50.00 | +81.55% | Reiterates | 2 months ago |
Assembly Biosciences IncASMB | 4 | Buy | $50.00 | +86.50% | Reiterates | 3 months ago |
Nrx Pharmaceuticals IncNRXP | 6 | Buy | $45.00 | +953.86% | Reiterates | 3 months ago |
Immunocore Holdings PLCIMCR | 4 | Buy | $100.00 | +186.04% | Reiterates | 3 months ago |
Voyager Therapeutics IncVYGR | 3 | Buy | $25.00 | +688.64% | Reiterates | 4 months ago |
Aligos Therapeutics IncALGS | 3 | Buy | $50.00 | +771.08% | Reiterates | 4 months ago |
Vir Biotechnology IncVIR | 3 | Buy | $20.00 | +112.09% | Maintains | 5 months ago |
Pharvaris NvPHVS | 4 | Buy | $60.00 | +71.72% | Reiterates | 5 months ago |
Definium Therapeutics IncDFTX | 1 | Buy | $70.00 | +58.05% | Maintains | 5 months ago |
Sangamo Therapeutics IncSGMO | 2 | Buy | $10.00 | +8,595.65% | Reiterates | 5 months ago |
Marker Therapeutics IncMRKR | 1 | Buy | $10.00 | +663.36% | Initiates Coverage On | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.